Home Medicine Bone Maturation in 1788 Children and Adolescents with Diabetes Mellitus Type 1
Article
Licensed
Unlicensed Requires Authentication

Bone Maturation in 1788 Children and Adolescents with Diabetes Mellitus Type 1

  • Axel Dost , Tilman Rohrer , Jörg Fussenegger , Christian Vogel , Bernd Schenk , Martin Wabitsch , Beate Karges , Claudia Vilser and Reinhard W. Holl
Published/Copyright: December 22, 2010
Journal of Pediatric Endocrinology and Metabolism
From the journal Volume 23 Issue 9

ABSTRACT

Diabetes mellitus type 1 might interfere with pubertal development. Particularly, longterm metabolic control and intensity of insulin treatment have been reported to contribute to a delay in pubertal onset. Data on somatic development in diabetic children are conflicting; therefore we studied bone age in 1788 children from Germany and Austria with type 1 diabetes. Bone age was retarded by -0.27 ± 1.1 years in the whole group, but particularly in the adolescents at the end of puberty (>16 years; -0.76±1.29y). Bone age delay was more pronounced in boys, and in children with longterm median HbA1c levels of 7.5 – 9.0%. No associations were found with current HbA1c levels or the intensity of insulin treatment. Bone age determinations in diabetic children should only be performed when clinical signs of impaired somatic development are present. In addition, the potential influence of diabetes on bone development needs to be considered in the interpretation of carpograms.


Corresponding author: Dr. Axel Dost, MD,

Published Online: 2010-12-22
Published in Print: 2010-September

© Freund Publishing House Ltd.

Articles in the same Issue

  1. The Soy That Surrounds Us: An Endless Debate
  2. Soy as an Endocrine Disruptor: Cause for Caution?
  3. Mass Ascites in Mulibrey Nanism
  4. Delayed Gastric Emptying in Patients with Prader Willi Syndrome
  5. Age and Sex Differences in Fat Distribution in Non-Obese Japanese Children
  6. Premature Thelarche in Taiwanese Girls
  7. Growth Hormone, Insulin Like Growth Factor-1, and Insulin-like Growth Factor-Binding Protein-3 Levels in the Neonatal Period: A Preliminary Study
  8. Bone Maturation in 1788 Children and Adolescents with Diabetes Mellitus Type 1
  9. Serum Thyroid Hormone Levels in Preterm Infants Born before 33 Weeks of Gestation and Association of Transient Hypothyroxinemia with Postnatal Characteristics
  10. Birth Length is a Predictor of Adiponectin Levels in Japanese Young Children
  11. Genotype-Phenotype Correlation in CAH Patients with Severe CYP21A2 Point Mutations in the Republic of Macedonia
  12. Benign Transient Hyperphosphatasemia of Infancy. A Common Benign Scenario, a Big Concern for a Pediatrician
  13. Scarcity Despite Wealth: Osteopetrorickets
  14. Growth Hormone Therapy and the Risk of Tumor Recurrence after Brain Tumor Treatment in Children
  15. Insulin Resistance and the Metabolic Syndrome in Obese Children Referred to an Obesity Center
  16. Severe Dietary Protein Sensitivity and Hyperinsulinemic Hypoglycemia in a Patient with Heterozygous Mutation in HADH Gene
  17. Neonatal Autoimmune Hypothyroidism: A Patient Report
  18. Adverse Effect of Phenytoin on Glucocorticoid Replacement in a Child with Adrenal Insufficiency
  19. Investigation of Acquired Von Willebrand Syndrome in Children with Hypothyroidism: Reversal after Treatment with Thyroxine
  20. Kabuki Syndrome and Crohn Disease in a Child with Familial Hypocalciuric Hypercalcemia
Downloaded on 11.12.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem.2010.144/pdf
Scroll to top button